111, Inc. Sponsored ADR (NASDAQ:YI – Get Free Report) saw a significant decrease in short interest in February. As of February 13th, there was short interest totaling 25,958 shares, a decrease of 33.5% from the January 29th total of 39,019 shares. Based on an average trading volume of 61,821 shares, the short-interest ratio is presently 0.4 days. Approximately 0.5% of the company’s shares are short sold. Approximately 0.5% of the company’s shares are short sold. Based on an average trading volume of 61,821 shares, the short-interest ratio is presently 0.4 days.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of 111 in a research report on Monday, December 29th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has a consensus rating of “Sell”.
Read Our Latest Stock Report on 111
111 Stock Down 2.1%
111 (NASDAQ:YI – Get Free Report) last released its quarterly earnings results on Wednesday, December 17th. The company reported ($1.20) earnings per share for the quarter. The firm had revenue of $421.49 million for the quarter.
About 111
111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.
111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.
Further Reading
- Five stocks we like better than 111
- Silver Crossed $100: Is the $500 surge next? (Join us March 4)
- America’s 1776 happening again
- 3 Signs You May Want to Switch Financial Advisors
- ATCX is Sitting on One of Brazil’s Largest Critical Minerals Portfolios!
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.
